Increased vascular endothelial growth factor transcription in residual hepatocellular carcinoma after open versus laparoscopic hepatectomy in a small animal model

Surgical Endoscopy

Volumn 24, Issue 5, 2010, Pages 1151-1157

  Perry, Kyle A ^a   Enestvedt, C Kristian ^a   Hosack, Luke W ^a   Pham, Thai H ^a   Diggs, Brian S ^a   Teh, Swee ^a   Orloff, Susan ^a   Winn, Shelly ^a   Hunter, John G ^a   Sheppard, Brett C ^a  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

Hepatocellular carcinoma; Laparoscopic hepatectomy; Vascular endothelial growth factor; VEGF

Indexed keywords

MESSENGER RNA; OSTEOPONTIN; RNA; VASCULOTROPIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER SURGERY; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GENE EXPRESSION REGULATION; INTERMETHOD COMPARISON; LAPAROSCOPIC SURGERY; LIVER CELL CARCINOMA; LIVER RESECTION; MINIMALLY INVASIVE SURGERY; NONHUMAN; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; QUANTITATIVE ANALYSIS; RAT; RECURRENCE RISK; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA EXTRACTION; TRANSCRIPTION REGULATION; TUMOR MICROENVIRONMENT; TUMOR VASCULARIZATION; TUMOR VOLUME;

EID: 77955658561     PISSN: 09302794     EISSN: 14322218     Source Type: Journal    
DOI: 10.1007/s00464-009-0742-6     Document Type: Article

References (41)

1. El-Serag HB, Mason AC (1999) Rising incidence of hepatocellular carcinoma in the United States. N Engl J Med 340:745-750.
2. El-Serag HB, Davila JA, Petersen NJ, Mc-Glynn KA (2003) The continuing increase in the incidence of hepatocellular carcinoma in the United States: an update. Ann Intern Med 139:817-823.
3. Poon RT, Fan ST, Lo CM, Ng IO, Liu CL, Lam CM, Wong J (2001) Improving survival results after resection of hepatocellular carcinoma: a prospective study of 377 patients over 10 years. Ann Surg 234:63-70.
4. Fong Y, Sun RL, Jarnagin W, Blumgart LH (1999) An analysis of 412 cases of hepatocellular carcinoma at a western center. Ann Surg 299:790-799.
5. Buell JF, Koffron AJ, Thomas MJ, Rudich S, Abecassis M, Woodle ES (2005) Laparoscopic liver resection. J Am Coll Surg 200:472-480.
6. Descottes B, Glineur D, Lachachi F, Valleix D, Paineau J, Hamy A, Morino M, Bismuth H, Castaing D, Savier E, Honore P, Detry O, Legrand M, Azagra JS, Goergen M, Ceuterick M, Marescaux J, Mutter D, de Hemptinne B, Troisi R, Weerts J, Dallemagne B, Jehaes C, Gelin M, Donckier V, Aerts R, Topal B, Bertrand C, Mansvelt B, Van Krunckelsven L, Herman D, Kint M, Totte E, Schockmel R, Gigot JF (2003) Laparoscopic liver resection of benign liver tumors. Surg Endosc 17:23-30.
7. Gigot JF, Glineur D, Santiago-Azagra J, Goergen M, Ceuterick M, Morino M, Etienne J, Marescaux J, Mutter D, van Krunckelsven L, Descottes B, Valleix D, Lachachi F, Bertrand C, Mansvelt B, Hubens G, Saey JP, Schockmel R, Hepatobilliary and Pancreatic Section of the Royal Belgian Society of Surgery and the Belgian Group for Endoscopic Surgery (2002) Laparoscopic liver resection for malignant liver tumors: preliminary results of a multicenter European study. Ann Surg 236:90-97.
8. Allendorf J, Bessler M, Kayton M, Oesterling SD, Treat MR, Nowygrod R, Whelan RL (1995) Increased tumor establishment and growth after laparotomy vs laparoscopy in a murine model. Arch Surg 130:649-653.
9. Bouvy N, Marquet R, Jeekel J, Bonjer H (1997) Laparoscopic surgery is associated with less tumor growth stimulation than conventional surgery: an experimental study. Br J Surg 84:358-361.
10. Da Costa M, Redmond H, Finnegan N, Flynn M, Bouchier-Hayes DJ (1998) Laparotomy and laparoscopy differentially accelerate experimental flank tumor growth. Br J Surg 85:1439-1442.
11. Gutt C, Riemer V, Kim Z, Jacobi CA, Paolucci V, Lorenz M (1999) Impact of laparoscopic colonic resection on tumor growth and spread in an experimental model. Br J Surg 86:1180-1184.
12. Shiromizu A, Suematsu T, Yamagichi K, Shiraishi N, Adachi Y, Kitano S (2000) Effect of laparotomy and laparoscopy on the establishment of lung metastasis in a murine model. Surgery 128:799-805.
13. Pera M, Nelson H, Rajkumar SV, Young-Fadok TM, Burgart LJ (2003) Influence of postoperative acute-phase response on angiogenesis and tumor growth: open vs laparoscopic-assisted surgery in mice. J Gastrointest Surg 7:783-790.
14. Mise M, Arii S, Higashituji H, Furutani M, Niwano M, Harada T, Ishigami S, Toda Y, Nakayama H, Fukumoto M, Fujita J, Imamura M (1996) Clinical significance of vascular endothelial growth factor and basic fibroblast growth factor gene expression in liver tumor. Hepatology 23:455-464.
15. Torimura T, Sata M, Ueno T, Kin M, Tsuji R, Suzaku K, Hashimoto O, Sugawara H, Tanikawa K (1998) Increased expression of vascular endothelial growth factor is associated with tumor progression in hepatocellular carcinoma. Hum Pathol 29:986-991.
16. Suzuki K, Hayashi N, Miyamoto Y, Yamamoto M, Ohkawa K, Ito Y, Sasaki Y, Yamaguchi Y, Nakase H, Noda K, Enomoto N, Arai K, Yamada Y, Yoshihara H, Tujimura T, Kawano K, Yoshikawa K, Kamada T (1996) Expression of vascular permeability factor/vascular endothelial growth factor in human hepatocellular carcinoma. Cancer Res 56:3004-3009.
17. Li XM, Tang ZY, Zhou G, Lui YK, Ye SL (1998) Significance of vascular endothelial growth factor mRNA expression in invasion and metastasis of hepatocellular carcinoma. J Exp Clin Cancer Res 17:13-17.
18. Moon WS, Rhyu KH, Kang MJ, Lee DG, Yu HC, Yeum JH, Koh GY, Tarnawski AS (2003) Overexpression of VEGF and angiopoietin 2: a key to high vascularity of hepatocellular carcinoma? Mod Pathol 16:552-557.
19. Poon RT, Ng IO, Lau C, Zhu LX, Yu WC, Lo CM, Fan ST, Wong J (2001) Serum vascular endothelial growth factor predicts venous invasion in hepatocellular carcinoma: a prospective study. Ann Surg 233:227-235.
20. Poon RT, Lau CP, Cheung ST, Yu WC, Fan ST (2003) Quantitative correlation of serum levels and tumor expression of vascular endothelial growth factor in patients with hepatocellular carcinoma. Cancer Res 63:3121-3126.
21. Yoshiji H, Kuriyama S, Yoshi J, Yamazaki M, Kikukawa M, Tsujinoue H, Nakatani T, Fukui H (1998) Vascular endothelial growth factor tightly regulates in vitro development of murine hepatocellular carcinoma cells. Hepatology 28:1489-1496.
22. Poon RTP, Ho JWY, Tong CSW, Lau C, Ng IOL, Fan ST (2004) Prognostic significance of serum vascular endothelial growth factor and endostatin in patients with hepatocellular carcinoma. Br J Surg 91:1354-1360.
23. Pan HW, Ou YH, Peng SY, Liu SH, Lai PL, Lee PH, Sheu JC, Chen CL, Hsu HC (2003) Overexpression of osteopontin is associated with intrahepatic metastasis, early recurrence, and poorer prognosis of surgically resected hepatocellular carcinoma. Cancer 98:119-127.
24. Zhao J, Dong L, Lu B, Wu G, Xu D, Chen J, Li K, Tong X, Dai J, Yao S, Wu M, Guo Y (2008) Downregulation of osteopontin suppresses growth of metastasis of hepatocellular carcinoma via induction of apoptosis. Gastroenterology 135:956-968.
25. Yang R, Rescorla F, Reilly C, Faught P, Sanghvi N, Lumeng L, Franklin T, Grosfeld J (1992) A reproducible rat liver cancer model for experimental therapy: introducing a new technique of intrahepatic tumor implantation. J Surg Res 52:193-198.
26. Carlsson G, Gullberg B, Hafstrom L (1983) Estimation of liver tumor volume using different formulas: an experimental study in rats. J Cancer Res Clin Oncol 105:20-23.
27. Primer 3 on the WWW for general users and for biologist programmers (computer program) (2000) Version Primer 3, Humana Press, Totowa, NJ.
28. Pfaffl MW (2001) A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res 29:e45.
29. Livak KJ, Schmittgen TD (2001) Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C[T]) method. Methods 25:402-408.
30. Hanahan D, Folkman J (1996) Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis. Cell 86:353-364.
31. Poon RT, Fan ST, Wong J (2001) Clinical implications of circulating angiogenic factors in cancer patients. J Clin Oncol 19:1207-1225.
32. Karayiannakis AJ, Syrigos KN, Polychronidis A, Zbar A, Kouraklis G, Simopoulos C, Karatzas G (2002) Circulating VEGF levels in the serum of gastric cancer patients: correlation with pathological variables, patient survival, and tumor surgery. Ann Surg 236:37-42.
33. Teknos TN, Cox C, Yoo S, Chepeha DB, Wolf GT, Bradford CR, Carey TE, Fisher SG (2002) Elevated serum vascular endothelial growth factor and decreased survival in advanced laryngeal carcinoma. Head Neck 24:1004-1011.
34. Cooper BC, Ritchie JM, Broghammer CL, Coffin J, Sorosky JI, Buller RE, Hendrix MJ, Sood AK (2002) Preoperative serum vascular endothelial growth factor levels: significance in ovarian cancer. Clin Cancer Res 8:3193-3197.
35. Harmon G, Senagore A, Kilbride M, Warzynski M (1994) Interleukin-6 response to laparoscopic and open colectomy. Dis Colon Rectum 37:754-759.
36. Leung K, Lai P, Ho R, Meng WCS, Yin RYC, Lee SFY, Lau WY (2000) Systemic cytokine response after laparoscopic-assisted resection of rectosigmoid carcinoma: a prospective randomized trial. Ann Surg 231:506-511.
37. Ordemann J, Jacobi C, Schwenk W, Stooslein R, Muller JM (2001) Cellular and humoral inflammatory response after laparoscopic and conventional colorectal resections: results of a prospective randomized trial. Surg Endosc 15:600-608.
38. Delgado S, Lacy A, Filella X, Castells A, García-Valdecasas JC, Pique JM, Momblán D, Visa J (2001) Acute-phase response in laparoscopic and open colectomy in colon cancer: randomized study. Dis Colon Rectum 44:638-646.
39. Cohen T, Nahari D, Cerem L, Neufeld G, Levi B (1996) Interleukin-6 induces the expression of vascular endothelial growth factor. J Biol Chem 271:736-741.
40. Akagi Y, Liu W, Xie K, Zebrowski B, Shaheen RM, Ellis LM (1999) Regulation of vascular endothelial growth factor expression in human colon cancer by interleukin-1b. Br J Cancer 80:1506-1511.
41. Jee S, Shen S, Chin H, Tsai WL, Kuo ML (2001) Overexpression of interleukin-6 in human basal cell carcinoma cell lines increases anti-apoptotic activity and tumorigenic potency. Oncogene 11:198-208.